Influence of Opioid Analgesia on Circulating Tumor Cells in Laparoscopic Colorectal Cancer Surgery
NCT ID: NCT03700541
Last Updated: 2023-12-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
71 participants
INTERVENTIONAL
2019-01-07
2023-12-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Morphine
Morphine-based perioperative analgesia
Morphine
Morphine intravenous
Piritramid
Piritramid-based perioperative analgesia
Piritramid
Piritramid intravenous
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Morphine
Morphine intravenous
Piritramid
Piritramid intravenous
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age over 18 years
* signed informed consent
Exclusion Criteria
* history of CRC surgery
* neoadjuvant therapy
* other malignancy not in permanent remission
* chronic opioid medication or opioid administration within 7 days preoperatively
* immunosuppressive or corticosteroid therapy
* surgery within 30 days preoperatively (except minor)
* chronic or acute infection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General University Hospital, Prague
OTHER
Tomas Bata Hospital, Czech Republic
OTHER
University Hospital Ostrava
OTHER
Hospital Novy Jicin
UNKNOWN
The Institute of Molecular and Translational Medicine, Czech Republic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marian Hajduch, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Institute of Molecular and Translational Medicine, Palacky University, Olomouc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
T. Bata Regional Hospital Zlin
Zlin, South Moravian, Czechia
University Hospital Ostrava
Ostrava, , Czechia
General University Hospital
Prague, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
POACC-2
Identifier Type: -
Identifier Source: org_study_id